SCHEMBL2298239

SCHEMBL2298239

CCOP(=O)(CC(=O)O)OCC.[PbH2]

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
PPARD Q03181 2/20 0.48
TDP1 Q9NUW8 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
TP53 P04637 1/20 0.39
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
FFAR3 O14843 1/20 0.35
HTT P42858 1/20 0.33
POLB P06746 1/20 0.33
NR1I2 O75469 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282439 0.98 TSHR (0.52) TSHRPPARDTDP1MEN1LMNA
SCHEMBL28021215 0.95 TSHR (0.50) TSHRPPARDTDP1MEN1LMNA
Hydrochloric Acid SCHEMBL15439306 0.95 TSHR (0.50) TSHRPPARDTDP1MEN1LMNA
Butane SCHEMBL2079484 0.93 TSHR (0.48) TSHRPPARDTDP1MEN1LMNA
Ether SCHEMBL28022888 0.91 TSHR (0.46) TSHRPPARDTDP1MEN1LMNA
Propene SCHEMBL28006041 0.87 TSHR (0.43) TSHRPPARDTDP1MEN1LMNA
SCHEMBL7528773 0.87 TSHR (0.43) TSHRPPARDTDP1MEN1LMNA
Acrylic Acid SCHEMBL28624578 0.86 TSHR (0.41) TSHRPPARDTDP1MEN1LMNA
SCHEMBL9332124 0.80 TSHR (0.44) TSHRPPARDTDP1MEN1KMT2A
SCHEMBL18250731 0.80 TSHR (0.55) TSHRPPARDTDP1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9260382-B2 Methods of reducing virulence in bacteria UWM RESEARCH FOUNDATION (US) 2016-02-16 US disclosed
EP-2536275-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA UWM Research Foundation, Inc. (US) 2012-12-26 EP disclosed
US-20120322769-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA DUKE UNIVERSITY (US) 2012-12-20 US disclosed
WO-2011103189-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA UWM RESEARCH FOUNDATION, INC. (US) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322769-A1 METHODS OF REDUCING VIRULENCE IN BACTERIA PGLS, RRS1, MRPL21 TSHR 1669/4885PPARD 4336/4885TDP1 2672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.